Correlation Between Reata Pharmaceuticals and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Reata Pharmaceuticals and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reata Pharmaceuticals and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reata Pharmaceuticals and Enveric Biosciences, you can compare the effects of market volatilities on Reata Pharmaceuticals and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reata Pharmaceuticals with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reata Pharmaceuticals and Enveric Biosciences.
Diversification Opportunities for Reata Pharmaceuticals and Enveric Biosciences
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reata and Enveric is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Reata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reata Pharmaceuticals are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Reata Pharmaceuticals i.e., Reata Pharmaceuticals and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Reata Pharmaceuticals and Enveric Biosciences
Given the investment horizon of 90 days Reata Pharmaceuticals is expected to generate 1.74 times more return on investment than Enveric Biosciences. However, Reata Pharmaceuticals is 1.74 times more volatile than Enveric Biosciences. It trades about 0.08 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.01 per unit of risk. If you would invest 3,766 in Reata Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 7,201 from holding Reata Pharmaceuticals or generate 191.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.85% |
| Values | Daily Returns |
Reata Pharmaceuticals vs. Enveric Biosciences
Performance |
| Timeline |
| Reata Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Enveric Biosciences |
Reata Pharmaceuticals and Enveric Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reata Pharmaceuticals and Enveric Biosciences
The main advantage of trading using opposite Reata Pharmaceuticals and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reata Pharmaceuticals position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.| Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |